The expression of the formin Fhod3 in mouse tongue striated muscle.

actin formin sarcomere striated muscle

Journal

Cell structure and function
ISSN: 1347-3700
Titre abrégé: Cell Struct Funct
Pays: Japan
ID NLM: 7608465

Informations de publication

Date de publication:
10 Oct 2024
Historique:
medline: 10 10 2024
pubmed: 10 10 2024
entrez: 9 10 2024
Statut: aheadofprint

Résumé

The sarcomere is the contractile unit of striated muscle and is composed of actin and myosin filaments. There is increasing evidence to support that actin assembly mediated by Fhod3, a member of the formin family of proteins, is critical for sarcomere formation and maintenance in cardiac muscle. Fhod3, which is abundantly expressed in the heart, localizes to the center of sarcomeres and contributes to the regulation of the cardiac function, as evidenced by the fact that mutations in Fhod3 cause cardiomyopathy. However, the role of Fhod3 in skeletal muscle, another type of striated muscle, is unclear. We herein show that Fhod3 is expressed in the tongue at both mRNA and protein levels, although in smaller amounts than in the heart. To determine the physiological role of Fhod3 expressed in the tongue, we generated embryos lacking Fhod3 in the tongue. The tongue tissue of the Fhod3-depleted embryos did not show any significant structural defects, suggesting that Fhod3 is dispensable for normal development of the mouse tongue. Unexpectedly, the immunostaining analysis revealed the absence of specific sarcomeric signals for Fhod3 in the wild-type tongue when compared to the Fhod3-depleted tongue as a negative control, despite the use of antibodies that had previously been validated by immunostaining of heart tissues. Taken together, although Fhod3 protein is expressed at a significant level in the tongue, Fhod3 in the tongue does not appear to exhibit the same sarcomeric pattern as observed in the heart, suggesting a different role for Fhod3 in the tongue muscles.Key words: actin, formin, sarcomere, striated muscle.

Identifiants

pubmed: 39384365
doi: 10.1247/csf.24044
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Hikaru Nakagawa (H)

Department of Pharmacology, Faculty of Medicine, University of Miyazaki.
Division of Oral and Maxillofacial Surgery, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, University of Miyazaki.

Yohko Kage (Y)

Department of Pharmacology, Faculty of Medicine, University of Miyazaki.

Ayako Miura (A)

Department of Pharmacology, Faculty of Medicine, University of Miyazaki.

Hikmawan Wahyu Sulistomo (HW)

Department of Pharmacology, Faculty of Medicine, University of Miyazaki.
Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya.

Sho Matsuyama (S)

Department of Pharmacology, Faculty of Medicine, University of Miyazaki.

Yoshihiro Yamashita (Y)

Division of Oral and Maxillofacial Surgery, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, University of Miyazaki.

Ryu Takeya (R)

Department of Pharmacology, Faculty of Medicine, University of Miyazaki.

Classifications MeSH